{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12522963",
  "DateCompleted": {
    "Year": "2003",
    "Month": "03",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2016",
    "Month": "11",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "rus"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0507-4088",
      "JournalIssue": {
        "Volume": "47",
        "Issue": "5",
        "PubDate": {
          "Year": "2002",
          "Season": "Sep-Oct"
        }
      },
      "Title": "Voprosy virusologii",
      "ISOAbbreviation": "Vopr Virusol"
    },
    "ArticleTitle": "[Effect of heroin-containing substances on the infectivity of the human immunodeficiency virus type 1 in vitro].",
    "Pagination": {
      "StartPage": "16",
      "EndPage": "20",
      "MedlinePgn": "16-20"
    },
    "Abstract": {
      "AbstractText": [
        "At room temperature, HIV-1 IIIB is shown to remain infectious in a dose of 25 mg/ml of heroin solution for more than 8 days. The large batch of HIV-1-contaminated heroin solution may therefore remain infectious for a long period sufficient for transportation, packing, and sale in any area of Russia. At the same time 41-day incubation under the same conditions caused a complete loss of viral infectivity. Under certain conditions (the concentration of MT-4 cells being less than 2 x 105 cells/ml and the multiplicity of infection, less than 0.01 ID50/cell), heroin was demonstrated to be able to increase HIV-1 replication at the early stages of its life cycle. The findings should be borne in mind in elaborating measures to prevent the spread of HIV-1 among intravenous psychoactive drug users."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Selimova",
        "ForeName": "L M",
        "Initials": "LM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Khanina",
        "ForeName": "T A",
        "Initials": "TA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kazennova",
        "ForeName": "E V",
        "Initials": "EV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zverev",
        "ForeName": "S Ia",
        "Initials": "SIa"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pokrovski\u012d",
        "ForeName": "V V",
        "Initials": "VV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bobkov",
        "ForeName": "A F",
        "Initials": "AF"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Vliianie preparata, soderzhashchego geroin, na infektsionnost' virusa immunodefitsita cheloveka tipa 1 in vitro."
  },
  "MedlineJournalInfo": {
    "Country": "Russia (Federation)",
    "MedlineTA": "Vopr Virusol",
    "NlmUniqueID": "0417337",
    "ISSNLinking": "0507-4088"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "70D95007SX",
      "NameOfSubstance": "Heroin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Heroin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "In Vitro Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Substance Abuse, Intravenous"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virulence"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Replication"
    }
  ]
}